Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Hultin

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Blood|November 1, 1979
Activated clotting factors in factor IX concentratesM B Hultin
Blood|July 1, 1985
Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and plateletsM B Hultin
Blood|September 1, 1983
Studies of factor IX concentrate therapy in hemophiliaM B Hultin
The American Journal of Medicine|November 4, 1991
Acquired inhibitors in malignant and nonmalignant disease statesM B Hultin
The Journal of Clinical Investigation|April 1, 1982
Role of human factor VIII in factor X activationM B Hultin
Blood|March 1, 1981
The activation and inactivation of human factor VIII by thrombin: effect of inhibitors of thrombinM B Hultin, J Jesty
Blood|November 1, 1978
Activation of factor X by factors IXa and VIII; a specific assay for factor IXa in the presence of thrombin-activated factor VIIIM B Hultin, Y Nemerson
Thrombosis Research|July 1, 1989
The use of polyelectrolyte-fractionated porcine factor VIII in the treatment of a spontaneously acquired inhibitor to factor VIIIM B Hultin, J Hennessey
Thrombosis Research|July 15, 1986
Factor IX concentrate therapy and thrombosis: relation to changes in plasma antithrombin IIIC Hoffman, M B Hultin
Thrombosis Research|January 15, 1987
Antithrombin antigen of high molecular weight associated with neoantigen in hemophilic plasma after factor IX concentrate therapyM B Hultin, U Abildgaard
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Blood|November 1, 1979
Activated clotting factors in factor IX concentratesM B Hultin
Blood|July 1, 1985
Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and plateletsM B Hultin
Blood|September 1, 1983
Studies of factor IX concentrate therapy in hemophiliaM B Hultin
The American Journal of Medicine|November 4, 1991
Acquired inhibitors in malignant and nonmalignant disease statesM B Hultin
The Journal of Clinical Investigation|April 1, 1982
Role of human factor VIII in factor X activationM B Hultin
Blood|March 1, 1981
The activation and inactivation of human factor VIII by thrombin: effect of inhibitors of thrombinM B Hultin, J Jesty
Blood|November 1, 1978
Activation of factor X by factors IXa and VIII; a specific assay for factor IXa in the presence of thrombin-activated factor VIIIM B Hultin, Y Nemerson
Thrombosis Research|July 1, 1989
The use of polyelectrolyte-fractionated porcine factor VIII in the treatment of a spontaneously acquired inhibitor to factor VIIIM B Hultin, J Hennessey
Thrombosis Research|July 15, 1986
Factor IX concentrate therapy and thrombosis: relation to changes in plasma antithrombin IIIC Hoffman, M B Hultin
Thrombosis Research|January 15, 1987
Antithrombin antigen of high molecular weight associated with neoantigen in hemophilic plasma after factor IX concentrate therapyM B Hultin, U Abildgaard
Pageof 4